What is the recommended treatment for Group B Streptococcus (GBS) pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ampicillin is a recommended treatment for Group B Streptococcus (GBS) pneumonia, with a typical dosage of 2 grams every 4-6 hours. The treatment of GBS pneumonia involves the use of intravenous antibiotics, with penicillin G and ampicillin being the preferred choices due to their effectiveness against GBS 1. For patients with penicillin allergy, alternative antibiotics such as clindamycin or vancomycin may be used 1. The duration of treatment is typically 10-14 days, depending on the clinical response of the patient 1. It is essential to note that GBS remains universally susceptible to penicillins, making them the first-line treatment 1. Supportive care, including oxygen therapy, respiratory support, and management of complications, is also crucial in the treatment of GBS pneumonia 1. The use of ampicillin for GBS pneumonia is supported by guidelines from reputable sources, which emphasize the importance of early and appropriate antibiotic therapy in reducing mortality and preventing complications 1. Key considerations in the treatment of GBS pneumonia include:

  • The use of intravenous antibiotics, such as ampicillin, as the preferred treatment 1
  • The importance of early and appropriate antibiotic therapy in reducing mortality and preventing complications 1
  • The need for supportive care, including oxygen therapy and respiratory support, in the management of GBS pneumonia 1
  • The consideration of alternative antibiotics, such as clindamycin or vancomycin, for patients with penicillin allergy 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION Infections of the respiratory tract and soft tissues. Treatment of all infections should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained A minimum of 10-days treatment is recommended for any infection caused by Group A beta-hemolytic streptococci to help prevent the occurrence of acute rheumatic fever or acute glomerulonephritis.

The recommended treatment for Group B Streptococcus (GBS) pneumonia is not explicitly stated in the provided drug label. However, based on the dosage recommendations for respiratory tract infections, Ampicillin can be considered a potential treatment option.

  • The dosage for patients weighing 40 kg (88 lbs) or more is 250 mg to 500 mg every 6 hours.
  • The dosage for patients weighing less than 40 kg (88 lbs) is 25 to 50 mg/kg/day in equally divided doses at 6- to 8-hour intervals. It is essential to note that the treatment should be continued for a minimum of 48 to 72 hours beyond the time the patient becomes asymptomatic or evidence of bacterial eradication has been obtained 2.

From the Research

Recommended Treatment for Group B Streptococcus (GBS) Pneumonia

  • The American Academy of Pediatrics and the American College of Obstetricians and Gynecologists recommend maternal intrapartum antibiotic prophylaxis based on antenatal screening for GBS colonization to prevent perinatal GBS disease 3.
  • Penicillin, ampicillin, or cefazolin are recommended for prophylaxis, with clindamycin and vancomycin reserved for cases of significant maternal penicillin allergy 3.
  • For neonates, ampicillin is frequently used for early- and late-onset GBS disease, with dosing recommendations based on the American Academy of Pediatrics guidelines 4.
  • However, the supporting evidence for ampicillin dosing recommendations, especially for meningitis, is limited, and high doses may increase the risk of seizures 4.

Antibiotic Susceptibility of GBS

  • GBS are generally susceptible to penicillins, including ampicillin, with universal susceptibility reported in some studies 5.
  • However, there have been reports of reduced susceptibility to beta-lactams, including penicillin, in some countries 6, 7.
  • Resistance to second-line antibiotics, such as erythromycin and clindamycin, remains high amongst GBS, with several countries noting increased resistance rates in recent years 5, 7.

Treatment Considerations

  • Ampicillin is a commonly used antibiotic for GBS pneumonia, but dosing recommendations should be carefully considered, especially for meningitis 4.
  • In cases of penicillin allergy, clindamycin or vancomycin may be used as alternative treatments, but resistance rates should be considered 3, 5, 7.
  • The development of antibiotic resistance in GBS is a concern, and treatment strategies should be guided by local resistance patterns and susceptibility testing 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.